Wigzell Hans Lennart Rudolf's Form 4 filing
Sarepta Therapeutics, Inc. (SRPT) · filed Aug 8, 2023
- Accession no.
- 0001209191-23-045095
- Filed
- Aug 8, 2023
- Trade date
- Aug 4, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.60M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wigzell Hans Lennart RudolfCIK 0001492766 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2023 | Common Stock | MOption exerciseAcquired | +15,000 | $29.03 | +$435,450 | 35,994 | Direct | |
| Aug 4, 2023 | Common Stock | SSaleDisposed | −15,000 | $106.72 | −$1,600,800 | 20,994 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2023 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.